Abstract
P73, a p53-homologue gene, has been studied for its possible role in head and neck squamous epithelium (HNSE) differentiation and carcinogenesis. P73 RNA and protein were analysed in 50 biopsies, including well- and moderately-differentiated carcinomas, and 21 matched normal adjacent tissues. P73 immunohistochemical analyses revealed intense p73 nuclear staining in basal and parabasal cells of normal squamous epithelium, in contrast with complete absence of staining in the more superficial cell layers. Moderately-differentiated carcinomas demonstrated homogeneous and diffuse staining in all tumour cells, while only basal cells were stained in well-differentiated carcinomas as in normal tissue. No correlation was observed between p73 and p53 protein expression. Immunostaining for p63, another p53-related protein previously described as being involved in HNSE morphogenesis and overexpressed in head and neck squamous cell carcinomas (HNSCC), was found to be similar to p73 labelling in carcinomas, but spread to the more differentiated layers in normal epithelium. Biallelic expression of p73 was found in tumours as well as in matched normal tissues. Comparison of p73 transcript levels between tumours and normal tissues showed decreased mRNA expression in 5/17 (30%) tumours independently of the differentiation status. Mutation and loss of heterozygosity analyses of the p73 gene revealed wild type status and no deletion. Our results strongly suggest that: (i) p73 is associated with homeostasis and control of differentiation of head and neck squamous epithelium probably in concert with p53 and p63; (ii) down-regulation of p73 expression could participate in HNSE carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahomadegbe JC, Barrois M, Fogel S, LeBihan ML, Douc-Rasy S, Duvillard P, Armand JP, Riou G . 1995 Oncogene 10: 1217–1227
Ahomadegbe JC, Tourpin S, Kaghad M, Zelek L, Vayssade M, Mathieu MC, Rochard F, Spielmann M, Tursz T, Caput D, Riou G, Bénard J . 2000 Oncogene 19: 5413–5418
Brash DE, Ponten J . 1998 Cancer Survey 32: 69–113
Brenner L, Muñoz-Antonia T, Vellucci VF, Zhou ZL, Reiss M . 1993 Cell Growth Differ. 4: 993–1004
Cai Y, Yang G, Nie Y, Wang LD, Zhao X, Song YL, Seril D, Liao J, Xing EP, Yang CS . 2000 Carcinogenesis 21: 683–689
Casciano I, Ponzoni M, Cunsolo C, Tonini G, Romani M . 1999 Cell Death Differ. 6: 391–393
Celli J, Duijf P, Hamel BCJ, Bamshad M, Kramer B, Smits APT, Newbury-Ecob R, Hennekam RCM, Van Buggenhout G, Van Haerigen A, Woods CG, Van Essen AJ, De Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, Van Bokhoven H . 1999 Cell 99: 143–153
De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G . 1998 J. Exp. Med. 188: 1763–1768
De Laurenzi V, Catani M, Costanzo A, Terrinoni A, Corazzari M, Levrero M, Knight R, Melino G . 1999 Cell Death Differ. 6: 389–390
Dobbelstein M, Wienzek S, König C, Roth J . 1999 Oncogene 18: 2101–2106
Hall PA, Campbell SJ, O'Neill M, Royston DJ, Nylander K, Carey FA, Kernohan NM . 2000 Carcinogenesis 21: 153–160
Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno S, Nimura Y, Nakagawara A, Horii A . 1999 Eur. J. Surg. Oncol. 25: 194–198
Harris CC, Hollstein M . 1993 New Engl. J. Med. 329: 1318–1327
Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidranski D . 2000 Proc. Natl. Acad. Sci. USA 97: 5462–5467
Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A . 1999 Oncogene 18: 1061–1066
Jost CA, Marin MC, Kaelin Jr WG . 1997 Nature 389: 191–194
Kaelin WG . 1999 J. Natl. Cancer I. 91: 594–598
Kaghad M, Bonnet H, Yang A, Creancler L, Biscan JC, Valent A, Minty A, Chalon P, Lellas JM, Dumont X, Ferrara P, McKeon F, Caput D . 1997 Cell 90: 809–819
Kang MN, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, Chi SG . 2000 Clin. Cancer Res. 6: 1767–1771
Levine AJ . 1994 Brit. J. Cancer 69: 409–416
Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR . 2000 Cancer Res. 60: 4016–4020
Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, Liu W . 1998 Cancer Res. 58: 2347–2349
Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin Jr WG . 1998 Mol. Cell. Biol. 18: 6316–6324
Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A . 1999 Nature 398: 708–713
Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S . 1998 Nat. Med. 4: 839–843
Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD . 2000 Science 289: 304–306
Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M . 1998 J. Virol. 72: 8510–8516
Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A, Goldfinger N . 1994 Semin. Cancer Biol. 5: 229–236
Senoo M, Seki N, Ohira M, Sugano S, Watanabe M, Tachibana M, Tanaka T, Shinkai Y, Kato H . 1998 Biochem. Biophys. Res. Commun. 248: 603–607
Shishikura T, Ichimiya S, Ozaki T, Nimura Y, Kegeyama H, Nakamura Y, Sakiyama S, Miyauchi M, Yamamoto N, Suzuki M, Nakajima N, Nakagawara A . 1999 Int. J. Cancer 84: 321–325
Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B . 1994 Int. J. Cancer 57: 1–9
Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG . 1999 Mol. Cell. Biol. 19: 3885–3894
Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidranski D . 1998 Nat. Med. 4: 747
Woodworth CD, Wang H, Simpson S, Alvarez-Salas LM, Notario V . 1993 Cell Growth Differ. 4: 367–376
Yamaguchi K, Wu L, Caballero OL, Hibi K, Trink B, Resto V, Cairns P, Okami K, Koch WM, Sidranski D, Jen J . 2000 Int. J. Cancer 86: 684–689
Yang A, Kaghad M, Wang Y, Gillet E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F . 1998 Mol. Cell 2: 305–316
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F . 1999 Nature 398: 714–718
Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D . 2000 Nature 404: 99–103
Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI, Liu W . 1999 Oncogene 18: 1629–1633
Zaika AI, Kovalev S, Marchenko ND, Moll UM . 1999 Cancer Res. 59: 3257–3263
Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin Jr WG, Oren M, Chen J, Lu H . 1999 Mol. Cell. Biol. 19: 3257–3266
Zhu J, Jiang J, Zhou W, Chen X . 1998 Cancer Res. 58: 5061–5065
Acknowledgements
This article is dedicated to Prof Guy Riou, Honorary Head of the Molecular Pharmacology Department of the Institute Gustave Roussy, in acknowledgement of his invaluable scientific and research teaching. We thank Pr Thierry Soussi for helpful criticisms, Sophie Tourpin for technical assistance and Dr Anthony Saul for editing this manuscript. This work was supported by grants from Sanofi-Recherches Labège, Institut Gustave Roussy Villejuif (CRC grant No 98-20), and La Ligue contre le Cancer ‘Comité des Hauts de Seine’ and ‘Comité du Val de Marne’ (France).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faridoni-Laurens, L., Bosq, J., Janot, F. et al. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?. Oncogene 20, 5302–5312 (2001). https://doi.org/10.1038/sj.onc.1204687
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204687
Keywords
This article is cited by
-
Clinical implications of the deregulated TP73 isoforms expression in cancer
Clinical and Translational Oncology (2018)
-
p73: Friend or foe in tumorigenesis
Nature Reviews Cancer (2002)